agilon health Inc (AGL)

Currency in USD
129.84
+8.62(+7.11%)
Closed·
133.24+3.40(+2.62%)
·
Trading near 52-week High
AGL is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
117.82133.04
52 wk Range
7.48133.04
Key Statistics
Prev. Close
129.84
Open
118.2
Day's Range
117.82-133.04
52 wk Range
7.48-133.04
Volume
370.65K
Average Volume (3m)
416.58K
1-Year Change
144.9811%
Book Value / Share
10.93
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
AGL Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
71.57
Downside
-44.88%
Members' Sentiments
Bearish
Bullish
ProTips
Significant return over the last week

agilon health Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Analyst Ratings

4 Buy
11 Hold
2 Sell
Ratings:
17 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 71.57
(-44.88% Downside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Wells Fargo
Buy141.00+8.60%72.00MaintainJul 13, 2026
Wells Fargo
Buy141.00+8.60%72.00MaintainJul 13, 2026
Citizens
Hold---MaintainJun 24, 2026
Barclays
Hold81.00-37.62%-UpgradeMay 26, 2026
Benchmark
Buy95.00-26.83%13.00MaintainMay 21, 2026

agilon health Inc SWOT Analysis


Profitability Push
Agilon Health pivots from rapid growth to profitability amid challenging financial results, including revenue decline and EBITDA losses in Q2 2025
Leadership Transition
CEO departure triggers strategic reevaluation, with focus shifting to operational efficiency and improved financial performance under interim leadership
Market Headwinds
Explore how medical cost pressures, declining membership, and cash burn impact Agilon's path to positive cash flow, projected for 2027
Analyst Outlook
Price targets range from $2 to $3, reflecting cautious market sentiment as Agilon navigates profitability challenges in the Medicare Advantage secto
Read full SWOT analysis

agilon health Inc Earnings Call Summary for Q1/2026

  • Agilon Health reported Q1 2026 EPS of $2.94, crushing forecasts of $0.06 with a 4,800% surprise; revenue reached $1.42B, slightly above expectations.
  • Stock surged 126.85% to $60.66 post-earnings, continuing to $70 in premarket trading; however, InvestingPro flags shares as potentially overvalued.
  • Medical margin rose 16.4% YoY to $149M while adjusted EBITDA jumped 157% to $54M, demonstrating strong operational improvements and cost management.
  • Full-year 2026 guidance set at $5.7B revenue, $375M medical margin, and $25M adjusted EBITDA; focus remains on disciplined growth and payer contracting.
  • Revenue declined 7.2% YoY due to membership reductions and strategic market exits; management maintains conservative cost outlook despite favorable trends.
Last Updated: 05/13/2026, 04:46 PM
Read Full Transcript

Earnings

Latest Release
May 06, 2026
EPS / Forecast
2.94 / 0.06
Revenue / Forecast
1.42B / 1.41B
EPS Revisions
Last 90 days

AGL Income Statement

Compare AGL to Peers and Sector

Metrics to compare
AGL
Peers
Sector
Relationship
P/E Ratio
−5.8x22.8x−0.4x
PEG Ratio
0.131.100.00
Price/Book
11.9x2.9x2.6x
Price / LTM Sales
0.4x1.2x3.0x
Upside (Analyst Target)
−43.4%19.5%53.2%
Fair Value Upside
Unlock5.6%9.0%Unlock

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. The company was founded in 2016 and is based in Westerville, Ohio.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
3.84M22.56%499.15M
Other Institutional Investors
12.97M77.44%1.68B
Public Companies & Retail Investors
0.000.00%0.00
Total
16.81M100.00%2.18B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Clayton, Dubilier & Rice, LLC23.98%4,000,000519,360
Morgan Stanley Investment Management Inc.12.40%2,068,404268,562

People Also Watch

4.150
RXT
-1.43%
71.84
MXL
-3.44%
14.550
MRAM
-0.85%
4.9600
MNTS
+1.85%
123.99
SPCX
-5.43%

FAQ

What Is the agilon health (AGL) Stock Price Today?

The agilon health stock price today is 129.84 USD.

What Stock Exchange Does agilon health Trade On?

agilon health is listed and trades on the New York Stock Exchange.

What Is the Stock Symbol for agilon health?

The stock symbol for agilon health is "AGL."

What Is the agilon health Market Cap?

As of today, agilon health market cap is 2.17B USD.

What Is agilon health's Earnings Per Share (TTM)?

The agilon health EPS (TTM) is -22.53.

When Is the Next agilon health Earnings Date?

agilon health will release its next earnings report on Aug 05, 2026.

From a Technical Analysis Perspective, Is AGL a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has agilon health Stock Split?

agilon health has split 1 times.

How Many Employees Does agilon health Have?

agilon health has 856 employees.

What is the current trading status of agilon health (AGL)?

As of Jul 20, 2026, agilon health (AGL) is trading at a price of 129.84 USD, with a previous close of 129.84 USD. The stock has fluctuated within a day range of 117.82 USD to 133.04 USD, while its 52-week range spans from 7.48 USD to 133.04 USD.

What Is agilon health (AGL) Price Target According to Analysts?

The average 12-month price target for agilon health is 71.57 USD, with a high estimate of 141 USD and a low estimate of 22 USD. 4 analysts recommend buying the stock, while 2 suggest selling, leading to an overall rating of Neutral. The stock has an -44.88% Downside potential.

What Is the AGL After Hours Price?

AGL's last after hours stock price is 133.24 USD, the stock has decreased by 3.40, or 2.62%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.